This BioProject represents "Non-Smoking Lung Cancer (NSLC)" cohort from the Korea National Genome Project.
A new wave of precision medicine has become an inevitable consequence of a drastic improvement in related technologies, including high-throughput sequencing and data analysis and sharing. Here, we briefly introduce the Korea National Genome Project (NGP), a pilot phase, which provides genome and clinical information from up to 25,000 participants: rare disease, cancer, and autism spectrum disorder patients and healthy participants. The NGP has been designed to encourage the scientific community to perform integrative analyses with the large-scale genome and clinical data, while protecting the participants’ privacy and securing data confidentiality. Our consortium generated whole genome sequencing (WGS) data from the collected blood or saliva samples. Furthermore, we have established the processing and quality control pipelines for the WGS data to call germline or somatic variants with consistency and confidence. All these processed WGS data and clinical information have been stored in the Research Environment Platform, and provided to the scientific community, enabling the researchers to conduct a multitude of integrative data analyses in the secured workspace.
The data of this BioProject are available in the Research Environment Platform (https://www.cirn.re.kr/).
